Ketamine

氯胺酮

Report date: 2026/05/20 20:02:01

Base Information

Drug NameKetamine
Drug Alias NameKetamine intranasalRVT-701KET-01
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSedationPreoperative AnxietyLevodopa-induced dyskinesia +[59
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[17
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesRoivant Sciences Inc
China Registration ClassN/A

Develop Information

Active IndicationsSedationPreoperative AnxietyLevodopa-induced dyskinesia +[49
Inactive IndicationsAutistic DisorderAnxietyComplex Regional Pain Syndromes +[10

Other Information

ATC CodeN01AX03